Deerfield Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.9M Sell
1,997,618
-193,382
-9% -$4.21M 0.59% 45
2026
Q1
$38M Hold
2,191,000
0.45% 54
2025
Q4
$41.3M Hold
2,191,000
0.53% 41
2025
Q3
$31.9M Buy
+2,191,000
New +$31.2M 0.49% 48
2024
Q4
Sell
-30,871
Closed -$964K 164
2024
Q3
$964K Buy
+30,871
New +$768K 0.01% 144
2016
Q3
Sell
-51,204
Closed -$221K 95
2016
Q2
$221K Sell
51,204
-177,796
-78% -$823K 0.01% 104
2016
Q1
$1.14M Hold
229,000
0.05% 93
2015
Q4
$1.47M Hold
229,000
0.06% 101
2015
Q3
$955K Hold
229,000
0.04% 125
2015
Q2
$1.49M Sell
229,000
-575,000
-72% -$3.12M 0.05% 111
2015
Q1
$4.46M Hold
804,000
0.14% 88
2014
Q4
$5.83M Buy
804,000
+229,000
+40% +$1.54M 0.21% 73
2014
Q3
$4.03M Buy
+575,000
New +$5.53M 0.15% 99

Other funds holding CDNA

Deerfield Management's CDNA Position: Q2 2026 in Review

Deerfield Management reduced its CareDx (CDNA) stake by 8.8% in Q2 2026, selling an estimated $4.21M and leaving 1,997,618 shares worth $56.9M. The position accounts for 0.59% of the portfolio, ranked #45.

Deerfield Management first reported a position in CDNA in Q3 2014 and has held it in 13 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Deerfield Management held 1,997,618 shares of CareDx worth $56.9M as of Q2 2026.
  • Deerfield Management sold 193,382 CareDx shares in Q2 2026, an estimated $4.21M.
  • CareDx made up 0.59% of Deerfield Management's portfolio in Q2 2026, its #45 holding.
  • Deerfield Management first reported a position in CareDx in Q3 2014 and has held it in 13 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.